Previous studies on MCF-7
breast cancer cells have shown that the
G-protein coupled receptor (GPCR) agonist
carbachol increases intracellular
calcium levels and the activation of
extracellular signal-regulated kinase (ERK).
Calcium and
calmodulin regulate the
calcium/
calmodulin-dependent
kinase (CaM
kinase) family of
proteins that have been proposed to regulate ERK and gene transcription. Our results suggest that both
estrogen (E2) and
carbachol treatment of MCF-7
breast cancer cells trigger phosphorylation of ERK1/2 and the
transcription factor Elk-1.
Carbachol and
estrogen triggered nearly a four- to sixfold increase in MCF-7 cell proliferation by 96 h, respectively.
Carbachol-stimulated ERK activation and cell growth was completely blocked by the
Muscarinic M(3)-subtype GPCR inhibitor,
4-DAMP, and
siRNA against the M(3)-subtype GPCR. Interestingly, blockade of
CaM KK with the selective inhibitor
STO-609 prevented
carbachol activation CaM KI, ERK, Elk-1, and cell growth. Consistent with these observations, knockdown of CaM KKalpha and CaM KIgamma with
shRNA-containing plasmids blocked ERK activation by
carbachol. In addition, Elk-1 phosphorylation and
luciferase activity in response to
carbachol treatment was also dependent upon CaM
kinases and was inhibited by
U0126,
STO-609, and
siRNA knockdown of CaM
kinases and ERK2. Finally, blockade of either
CaM KK (with STO-609) or ERK (with
U0126) activities resulted in the inhibition of
carbachol- and
estrogen-mediated
cyclin D1 expression and MCF-7 cell growth. Taken together, our results suggest that
carbachol treatment of MCF-7 cells activates CaM KI, ERK, the
transcription factor Elk-1,
cyclin D1, and cell growth through
CaM KK.